Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S Tekijä Mohamed I. M. Ahmed, Michael Plank, Noemi Castelletti, Paulina Diepers, Tabea M. Eser, Raquel Rubio-Acero, Ivan Noreña, Christina Reinkemeyer, Dorinja Zapf, Michael Hoelscher, Christian Janke, Andreas Wieser, Christof Geldmacher, on behalf of the KoCo19/ORCHESTRA Study Group

Hae kokoteksti